Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Carcinoma In Situ × Absorptiometry, Photon × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Prostatic Neoplasms 3 Lymphoma, Non-Hodgkin 2 Wilms Tumor 1 Smoldering Multiple Myeloma 1 Sarcoma, Ewing 1 Ovarian Neoplasms 1 Osteosarcoma 1 Osteoporosis 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Monoclonal Gammopathy of Undetermined Significance 1 Melanoma 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hodgkin Disease 1 Hepatoblastoma 1 Hematopoietic and Lymphoid System Neoplasm 1 Endometrial Neoplasms 1 Desmoid Tumors 1 Colorectal Neoplasms 1 Clinical Stage III Cutaneous Melanoma AJCC v8 1 Carcinoma, Hepatocellular 1 Breast Carcinoma In Situ 1

Interventions

Specimen Handling 7 Tamoxifen 5 Practice Guidelines as Topic 5 Standard of Care 4 Radiotherapy 3 Methods 3 Sentinel Lymph Node Biopsy 2 Radiation 2 Interviews as Topic 2 Educational Status 2 Early Intervention, Educational 2 Counseling 2 pembrolizumab 1 exemestane 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 abemaciclib 1 Watchful Waiting 1 Telemedicine 1 Taxes 1 Tablets 1 Surveys and Questionnaires 1 Starch 1 Reverse Transcriptase Polymerase Chain Reaction 1 Ranitidine 1 Radiosurgery 1 Radiation Dose Hypofractionation 1 Protons 1 Proton Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06671912 2026-03-04

LoTam

Alliance for Clinical Trials in Oncology

Phase 3 Suspended

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡